APA (7th ed.) Citation

AM, F., LM, B., C, M., A, S., ZA, B., M, W., . . . EDG, F. (2026). Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.MCT-25-0736

Chicago Style (17th ed.) Citation

AM, Fordham, et al. "Comprehensive Multi-platform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations Across Sarcomas Affecting the Young." Molecular Cancer Therapeutics 2026. https://doi.org/10.1158/1535-7163.MCT-25-0736.

MLA (9th ed.) Citation

AM, Fordham, et al. "Comprehensive Multi-platform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations Across Sarcomas Affecting the Young." Molecular Cancer Therapeutics, 2026, https://doi.org/10.1158/1535-7163.MCT-25-0736.